Literature DB >> 12709868

Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?

Renaud A Du Pasquier1, Igor J Koralnik.   

Abstract

Progressive multifocal leukoencephalopathy (PML) occurs in patients with profound immunosuppression. Although lesions are usually devoid of lymphoplasmocytic infiltrates, inflammatory forms of PML have been described, in both human immunodeficiency virus (HIV)-seropositive (HIV+) and -seronegative (HIV-) patients. In addition, PML has been shown to develop in HIV+ patients shortly after introduction of highly active antiretroviral therapy (HAART), despite a recovery of the immune system. Therefore, one could postulate that PML might arise in the context of an immune reconstitution syndrome. To examine the clinical and neuroradiological characteristics of inflammatory forms of PML, the authors performed a retrospective analysis of the patients seen at their institution since 1996 as well as a review of the literature. Of 39 HIV+ and HIV- PML patients, 5 (13%) presented with an inflammatory form of this disease. Two HIV+ patients developed PML soon after the onset of HAART, concomitant to immune recovery, as demonstrated by a decrease of HIV viral load (VL) and an increase of CD4+ T-cell count. Three patients (2 HIV+ and 1 HIV-) had signs of inflammation in the central nervous system (CNS) characterized by contrast-enhancing lesions on neuroimaging studies, and/or inflammatory infiltrates on brain biopsy. The presence of JC virus-specific cytotoxic T lymphocytes was demonstrated in 4/4 patients tested and the outcome was favorable in 3 of them. In agreement with previously published case reports, the data indicate that inflammatory reactions in PML are not infrequent, and that they are generally associated with a favorable prognosis. Therefore clinicians should not disregard the diagnosis of PML in presence of contrast-enhancing brain lesions, and should use caution before treating these immunosuppressed individuals with steroids.

Entities:  

Mesh:

Year:  2003        PMID: 12709868     DOI: 10.1080/13550280390195315

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  31 in total

1.  Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.

Authors:  J Gasnault; Y Taoufik; C Goujard; P Kousignian; K Abbed; F Boue; E Dussaix; J F Delfraissy
Journal:  J Neurovirol       Date:  1999-08       Impact factor: 2.643

2.  AIDS- and non-AIDS-related PML association with distinct p53 polymorphism.

Authors:  C Power; J G Gladden; W Halliday; M R Del Bigio; A Nath; W Ni; E O Major; J Blanchard; M Mowat
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

3.  HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

Authors:  D B Clifford; C Yiannoutsos; M Glicksman; D M Simpson; E J Singer; P J Piliero; C M Marra; G S Francis; J C McArthur; K L Tyler; A C Tselis; N E Hyslop
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

4.  The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

Authors:  P Cinque; C Pierotti; M G Viganò; A Bestetti; C Fausti; D Bertelli; A Lazzarin
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 5.  Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Richard J Hamill; Maria C Rodriguez-Barradas; Stephen B Greenberg; Robert L Atmar; Daniel W Musher; Joseph C Gathe; Fehmida Visnegarwala; Barbara W Trautner
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

6.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy.

Authors:  C T Yiannoutsos; E O Major; B Curfman; P N Jensen; M Gravell; J Hou; D B Clifford; C D Hall
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

8.  Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals.

Authors:  I J Koralnik; J E Schmitz; M A Lifton; M A Forman; N L Letvin
Journal:  J Neurovirol       Date:  1999-08       Impact factor: 2.643

9.  Subclinical central nervous system infection with JC virus in patients with AIDS.

Authors:  E B Quinlivan; M Norris; T W Bouldin; K Suzuki; R Meeker; M S Smith; C Hall; S Kenney
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

10.  JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.

Authors:  R A Du Pasquier; K W Clark; P S Smith; J T Joseph; J M Mazullo; U De Girolami; N L Letvin; I J Koralnik
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 3.739

View more
  36 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.

Authors:  C Buckle; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

Review 3.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

4.  Case 15: when a stroke is not a stroke.

Authors:  W Bryan Burnette
Journal:  MedGenMed       Date:  2007-01-30

Review 5.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

6.  [Introduction to the topic: immune reconstitution syndrome - relevance for the rheumatologist].

Authors:  E Märker-Hermann
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

7.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

8.  Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.

Authors:  Rainer Gosert; Piotr Kardas; Eugene O Major; Hans H Hirsch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 9.  Immunology of progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Ilijas Jelcic; Wolfgang Faigle; Mireia Sospedra; Roland Martin
Journal:  J Neurovirol       Date:  2015-03-05       Impact factor: 2.643

Review 10.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.